Zhitong Finance App News, Kanghong Pharmaceutical (002773.SZ) issued an announcement. Recently, the company's subsidiary Chengdu Kanghong Biotechnology Co., Ltd. (“Kanghong Biology”) received the KHN923 injection “Drug Clinical Trial Approval Notice” issued by the State Drug Administration. The drug's indication: Alzheimer's disease.

Zhitongcaijing · 1d ago
Zhitong Finance App News, Kanghong Pharmaceutical (002773.SZ) issued an announcement. Recently, the company's subsidiary Chengdu Kanghong Biotechnology Co., Ltd. (“Kanghong Biology”) received the KHN923 injection “Drug Clinical Trial Approval Notice” issued by the State Drug Administration. The drug's indication: Alzheimer's disease.